Research announcement · University of Surrey · 2025-09-23
A UK research team found that taking vitamin D2 was associated with lower concentrations of a blood marker derived from vitamin D3.
Researchers at Surrey, the John Innes Centre and Quadram Institute Bioscience examined trials comparing vitamin D2 supplements with a control. They wanted to know what happened to the part of a vitamin D blood measurement that comes from D3.
Of 20 trials in the review, 11 contributed to pooled analyses. Across those comparisons the blood concentration of 25-hydroxyvitamin D3 was lower in participants taking D2.
The pooled comparison of end-of-trial measurements put the D3-derived marker about 18 nmol/L lower in the D2 groups. The estimate was about 9 nmol/L lower in a separate analysis of how far the marker had moved since the start of each trial.
